B. Vucelic et al., DIFFERENCES IN SERUM SELENIUM CONCENTRATI ONS OF HEALTHY-PERSONS AND PATIENTS WITH COLORECTAL NEOPLASIA IN ZAGREB, CROATIA, Acta medica austriaca, 21(1), 1994, pp. 19-23
Serum selenium concentration (scSe) (mug/l) was comparatively measured
in healthy persons (n = 202), patients with colorectal adenoma(s) (n
= 44) and colorectal carcinoma (n = 48). In patients with adenoma(s) s
cSe (59.05 +/- 15) was significantly lower (p < 0,001) compared with s
cSe in the control group (66.8 +/- 14.43). Hyposelenemia was more pron
ounced in patients with multiple polyps (n = 11) than in patients with
single adenoma (n = 33) (p < 0.05). Patients with colorectal carcinom
a had also significant decrease in scSe (50.93 +/- 13.81) compared wit
h the control group (p < 0.001 and with the adenoma patients (p < 0.00
1). According to the analysis of variance, highly significant differen
ces were found among the cancer patients stratified in Dukes' stages A
to D (p < 0.001), indicating a strong negative correlation between ex
tension of cancer and hyposelenemia. Furthermore, hyposelenemia seemed
to be more pronounced in the mucinous type of carcinoma than in adeno
carcinoma (p = 0.056). This results indicate that hyposelenemia is str
ongly associated with colorectal neoplasia (including extension and se
verity of the disease) and that it may not only be a result but also o
ne of tumorogenic factors. That means that selenium supplementation co
uld be important in prevention or even adjuvant therapy of colorectal
cancer.